152 related articles for article (PubMed ID: 36536575)
1. [Association study of serum LncRNA MALAT1 and SAA with type 2 diabetic kidney disease].
Gao HJ; Qiao YC; Zhang YY; Wang YR; Niu WY
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1838-1843. PubMed ID: 36536575
[TBL] [Abstract][Full Text] [Related]
2. Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance.
Zhou LJ; Yang DW; Ou LN; Guo XR; Wu BL
J Diabetes Res; 2020; 2020():4729019. PubMed ID: 32832561
[TBL] [Abstract][Full Text] [Related]
3. Interplay between long non-coding RNA MALAT1 and pyroptosis in diabetic nephropathy patients.
Shoeib HM; Keshk WA; Al-Ghazaly GM; Wagih AA; El-Dardiry SA
Gene; 2023 Jan; 851():146978. PubMed ID: 36270460
[TBL] [Abstract][Full Text] [Related]
4. Association of the longitudinal trajectory of urinary albumin/creatinine ratio in diabetic patients with adverse cardiac event risk: a retrospective cohort study.
Li H; Ren Y; Duan Y; Li P; Bian Y
Front Endocrinol (Lausanne); 2024; 15():1355149. PubMed ID: 38745945
[TBL] [Abstract][Full Text] [Related]
5. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
6. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
7. Effect of glycemic control on microalbuminuria development among type 2 diabetes with high-normal albuminuria.
Chen WZ; Hung CC; Wen YW; Ning HC; Gau BR; Huang YY
Ren Fail; 2014 Mar; 36(2):171-5. PubMed ID: 24028605
[TBL] [Abstract][Full Text] [Related]
8. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
9. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus.
Boronat M; García-Cantón C; Quevedo V; Lorenzo DL; López-Ríos L; Batista F; Riaño M; Saavedra P; Checa MD
Ren Fail; 2014 Mar; 36(2):166-70. PubMed ID: 24059817
[TBL] [Abstract][Full Text] [Related]
10. Expression and diagnostic value of lncRNA MALAT1 and NLRP3 in lower limb atherosclerosis in diabetes.
Li J; Wang C; Shao C; Xu J
BMC Endocr Disord; 2024 Mar; 24(1):28. PubMed ID: 38439031
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model.
Wu D; Cheng YG; Huang X; Zhong MW; Liu SZ; Hu SY
J Physiol Biochem; 2018 Aug; 74(3):431-439. PubMed ID: 29781038
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus.
Kumon Y; Suehiro T; Itahara T; Ikeda Y; Hashimoto K
Clin Biochem; 1994 Dec; 27(6):469-73. PubMed ID: 7535207
[TBL] [Abstract][Full Text] [Related]
14. [Blood Lipid Indicators and Different Clinical Classifications of Dyslipidemia and Diabetic Kidney Disease: Correlation and Predictive Value].
Hu Y; Du X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):1013-1018. PubMed ID: 37866961
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs may impact podocytes and proximal tubule function through modulating miRNAs expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus patients.
Petrica L; Hogea E; Gadalean F; Vlad A; Vlad M; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Motoc A; Cretu OM; Radu D; Milas O; Golea-Secara A; Simulescu A; Mogos-Stefan M; Patruica M; Balint L; Ienciu S; Vlad D; Popescu R
Int J Med Sci; 2021; 18(10):2093-2101. PubMed ID: 33859515
[No Abstract] [Full Text] [Related]
16. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
[TBL] [Abstract][Full Text] [Related]
17. Performance of urinary vitamin D-binding protein in diabetic kidney disease: a meta-analysis.
Chen H; Ni L; Wu X
Ren Fail; 2023; 45(2):2256415. PubMed ID: 37870829
[No Abstract] [Full Text] [Related]
18. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease.
Shao Y; Ren H; Lv C; Ma X; Wu C; Wang Q
Endocrine; 2017 Jan; 55(1):130-138. PubMed ID: 27522360
[TBL] [Abstract][Full Text] [Related]
19. Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study.
Ren H; Wu C; Shao Y; Liu S; Zhou Y; Wang Q
Front Med; 2020 Oct; 14(5):642-650. PubMed ID: 31950345
[TBL] [Abstract][Full Text] [Related]
20. Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus.
Jiang Y; Li J; Zhang J; Chen S
Front Endocrinol (Lausanne); 2023; 14():1274025. PubMed ID: 38075072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
